You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma Relapse

Showing 1 - 25 of 9,491
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Factors of CMV Reactivation in Patients Receiving of CAR-T Cells

Not yet recruiting
  • Cytomegalovirus Infections
  • +2 more
    • (no location specified)
    Sep 22, 2023

    Lymphoma, Follicular Trial (Mosunetuzumab)

    Not yet recruiting
    • Lymphoma, Follicular
    • (no location specified)
    May 8, 2023

    NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

    Suspended
    • NHL
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 31, 2023

    SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • +2 more
      • (no location specified)
      Jun 22, 2023

      T-cell Acute Lymphoblastic Leukemia, T-lymphoblastic Lymphoma Trial in Kunming (Target CD7 CAR-T cells)

      Withdrawn
      • T-cell Acute Lymphoblastic Leukemia
      • T-lymphoblastic Lymphoma
      • Target CD7 CAR-T cells
      • Kunming, Yunnan, China
        920th Hospital of Joint Logistics Support Force of People's Libe
      Nov 23, 2022

      DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)

      Recruiting
      • Diffuse Large B-Cell Lymphoma
      • +3 more
      • Molecular Nanotechnology
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jun 2, 2022

      Hodgkin Lymphoma, Relapse, Refractory Trial in Chapel Hill (Chemotherapy, Cell infusion)

      Not yet recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Chapel Hill, North Carolina
        Lineberger Comprehensive Cancer Center
      Oct 13, 2023

      Adult Acute Lymphocytic Leukemia Trial in Frankfurt (Depocyt, Dexamethasone)

      Completed
      • Adult Acute Lymphocytic Leukemia
      • Frankfurt, Germany
        University Hospital, Medical Dept. II
      Aug 16, 2022

      Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • +3 more
      • Low-Dose Decitabine plus anti-PD-1
      • Beijing, Beijing, China
        ChinaPLAGH
      Apr 18, 2023

      MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

      Recruiting
      • Myelodysplastic Syndromes, de Novo
      • +10 more
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 23, 2023

      The Potential of Patient-reported Outcome Measures in Detection

      Recruiting
      • Diffuse Large B Cell Lymphoma
      • Patient Reported Outcome
      • No intervention
      • Copenhagen, Denmark
        Therese Lassen
      Mar 18, 2022

      B-cell Lymphoma Trial in Hangzhou (PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells)

      Active, not recruiting
      • B-cell Lymphoma
      • PD1 specific integrated anti-CD19 Chimeric Antigen Receptor T Cells
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital, Zhejiang University School of Med
      Sep 28, 2022

      Lymphoma, B-Cell Trial in Belgium, France (Valemetostat tosylate)

      Recruiting
      • Lymphoma, B-Cell
      • Valemetostat tosylate
      • Bruges, Belgium
      • +21 more
      Jan 9, 2023

      ACUTE LYMPHOBLASTIC LEUKEMIA Trial (Inotuzumab ozogamicin, ALLR3)

      Not yet recruiting
      • ACUTE LYMPHOBLASTIC LEUKEMIA
      • (no location specified)
      Feb 17, 2023

      Acute Myeloid Leukemia, MDS, Myeloproliferative Tumor Trial in Boston (CIML NK, Fludarabine, Cyclophosphamide)

      Recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • CIML NK
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Jan 6, 2023

      B-cell Lymphoma Trial in Beijing, Guangzhou (LP-168 tablet)

      Recruiting
      • B-cell Lymphoma
      • LP-168 tablet
      • Beijing, Beijing, China
      • +2 more
      Feb 24, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CD19 specific Chimeric Antigen Receptor T Cell
      • Columbus, Ohio
        Nationwide Children's Hospital
      Mar 9, 2023

      T Lymphoblastic Leukemia/Lymphoma, T-cell Acute Lymphoblastic Leukemia, Peripheral T Cell Lymphoma Trial in Shanghai (anti-CD7

      Recruiting
      • T Lymphoblastic Leukemia/Lymphoma
      • +4 more
      • anti-CD7 CAR-T cells
      • Shanghai, China
        Xianmin General Song
      Aug 29, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 16, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Feb 22, 2023

      Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Marginal Zone Lymphoma Trial in France (Atezolizumab, Obinutuzumab,

      Completed
      • Follicular Lymphoma
      • +3 more
      • Angers, France
      • +24 more
      Jan 9, 2023

      Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent DLBCL, Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Trial

      Active, not recruiting
      • Recurrent B-Cell Non-Hodgkin Lymphoma
      • +7 more
      • Jacksonville, Florida
      • +11 more
      Jan 12, 2023

      Acute Lymphoblastic Leukemia, in Relapse, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent,

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +4 more
      • Utrecht, Netherlands
        Princess Máxima Center for Pediatric Oncology
      Dec 13, 2022

      Lymphoma, B-Cell Trial in Philadelphia (CD19 redirected autologous T cells (CTL019 or CTL119 cells))

      Not yet recruiting
      • Lymphoma, B-Cell
      • CD19 redirected autologous T cells (CTL019 or CTL119 cells)
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Mar 18, 2022

      Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

      Not yet recruiting
      • Leukemia
      • +12 more
      • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
      • (no location specified)
      Mar 20, 2023